The National Directorate of Pharmacy and Drugs, under the Ministry of Health, has published Resolution No. 226, which orders the inclusion of safety information in the monographs and package inserts of registered products, those undergoing sanitary registration or renewal, and all new registration applications containing probiotics in their formulation.